Page last updated: 2024-08-21

thiazoles and Behavior Disorders

thiazoles has been researched along with Behavior Disorders in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-199013 (28.26)18.7374
1990's1 (2.17)18.2507
2000's24 (52.17)29.6817
2010's8 (17.39)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siegfried, N; Stein, DJ; Temmingh, HS; Williams, T1
Biesdorf, C; Diniz, A; Martins, FS; Sy, SKB1
Shrestha, R1
Geyer, MA; Higa, KK; Ji, B; Kim, M; Young, JW; Zhou, L; Zhou, X1
Bate, ST; Boléa, C; Browne, SE; Campo, B; Celanire, S; Davis, MJ; Duvoisin, R; Fonsi, M; Girard, F; Kalinichev, M; Le Poul, E; Poli, S; Raber, J; Reynolds, IJ; Royer-Urios, I; Uslaner, JM1
Connolly, JG; Schneeweiss, MC; Toomey, TJ1
Al-Jadiri, A; Azzo, S; Carbon, M; Correll, CU; Kane, JM; Kapoor, S; Saito, E; Sarkaria, T; Sheridan, E1
Gründer, G; Hiemke, C; Kircher, T; Leube, D; Saur, R; Schlotterbeck, P; Vehren, T1
Price, LH1
DeLorenze, G; L'Italien, G; McQuade, R; Newcomer, J; Oliveria, SA; Quesenberry, CP; Tsai, AL; Willey, VJ; Yood, MU1
Helm, ME; Henderson, C; Martin, BC; Pathak, P; West, D1
ASSAILLY, AA; DELAY, J1
Chowdhury, WA; Firoz, AH; Mamun, AA; Rahman, AH1
Black, KJ; Hershey, T; Koller, JM; Mintun, MA; Perlmutter, JS; Price, JL; Videen, TO1
Cohen, S; Fitzgerald, B; Khan, A; Khan, S; Okos, A1
Bailey, RK1
Ramos, AE; Sanberg, PR; Shytle, RD; Silver, AA1
BOUDIN, G; LAURAS, A; SALOMON, JC; SLIOSBERG, R1
HALPERN, S; KRUMHOLZ, W; MERLIS, S; TURNER, WJ1
GIACOBINI, E; IZIKOWITZ, S; NYGREN, S; SALUM, I1
SALUM, I1
BERGENER, M; FRITSCHKA, J1
SATTES, H1
GASTAGER, H; HAAS, I; WEINKAMER, E1
Findling, RL; McNamara, NK1
Citrome, L; Volavka, J1
Guilleminault, C; Martinez, S1
Bobes, J; Cañas, F; Mackell, J; Rejas, J1
Baldassano, C; Ballas, C; Ballas, P; O'Reardon, J; Yang, C1
Fukuda, K; Ishida, S; Kageyama, M; Miyauchi, T; Ohashi, Y1
Ahlskog, JE; Bower, JH; Josephs, KA; Klos, KJ; Matsumoto, JY1
Stocchi, F1
Correll, CU1
Asami, T; Hirayasu, Y; Kato, D; Kawanishi, C; Nakamura, S; Roppongi, T; Shiozaki, K; Togo, T; Yoshimi, A1
de Oliveira Lança, G; Hara, C; Kascher, GG; Magalhães Scoralick, F; Ramos, MG; Rocha, FL; Santos, MA1
Delgado, SV; Saldaña, SN1
Lebovitz, HE; Loebel, AD; Newcomer, JW; Weiden, PJ; Yang, R1
Wooten, J1
Barzman, DH; DelBello, MP; Forrester, JJ; Keck, PE; Strakowski, SM1
Eidelman, P; Nierenberg, AA; Smoller, JW; Tilley, CA; Wu, YP1
Cummings, JL1
Ripani, G; Trasatti, GA1
Babikow, PW; Kurland, AA; Pinto, A; Simopoulos, AM1
Burke, TF; Templar, DI1
Helmchen, H1
Lundquist, G1

Reviews

8 review(s) available for thiazoles and Behavior Disorders

ArticleYear
Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
    The Cochrane database of systematic reviews, 2018, Jan-22, Volume: 1

    Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Diagnosis, Dual (Psychiatry); Humans; Mental Disorders; Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Substance-Related Disorders; Thiazoles

2018
Brief report on Ziprasidone.
    Mymensingh medical journal : MMJ, 2002, Volume: 11, Issue:2

    Topics: Antipsychotic Agents; Humans; Mental Disorders; Piperazines; Thiazoles

2002
Atypical psychotropic medications and their adverse effects: a review for the African-American primary care physician.
    Journal of the National Medical Association, 2003, Volume: 95, Issue:2

    Topics: Adult; Aged; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Black or African American; Bone Marrow Diseases; Child; Dibenzothiazepines; Endocrine System Diseases; Humans; Mental Disorders; Nervous System Diseases; Olanzapine; Piperazines; Pirenzepine; Primary Health Care; Quetiapine Fumarate; Risperidone; Thiazoles

2003
Atypical antipsychotics in the treatment of children and adolescents: clinical applications.
    The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 6

    Topics: Adolescent; Age Factors; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Child; Child Development Disorders, Pervasive; Clozapine; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Tic Disorders

2004
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
    Postgraduate medicine, 2004, Volume: 116, Issue:4

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain

2004
Ziprasidone: a novel psychotropic with unique properties.
    Expert review of neurotherapeutics, 2004, Volume: 4, Issue:2

    Topics: Antipsychotic Agents; Clinical Trials as Topic; Humans; Mental Disorders; Piperazines; Schizophrenia; Thiazoles

2004
Metabolic effects of the atypical antipsychotics.
    Southern medical journal, 2007, Volume: 100, Issue:8

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dyslipidemias; Glucose Metabolism Disorders; Humans; Insulin Resistance; Mental Disorders; Obesity; Olanzapine; Phenothiazines; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles

2007
D-3 receptor agonists: combined action neurologic and neuropsychiatric agents.
    Journal of the neurological sciences, 1999, Feb-01, Volume: 163, Issue:1

    Topics: Animals; Benzothiazoles; Dopamine Agonists; Humans; Mental Disorders; Nervous System Diseases; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles

1999

Trials

6 trial(s) available for thiazoles and Behavior Disorders

ArticleYear
Weight, lipids, glucose, and behavioral measures with ziprasidone treatment in a population with mental retardation.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:1

    Topics: Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Intellectual Disability; Lipids; Male; Mental Disorders; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome; Triglycerides

2003
Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:8

    Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dyskinesia, Drug-Induced; Follow-Up Studies; Haloperidol; Hospitalization; Humans; Mental Disorders; Models, Econometric; Olanzapine; Outpatients; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Sensitivity and Specificity; Spain; Survival Analysis; Thiazoles; Treatment Outcome; Weight Gain

2004
An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia.
    Dementia and geriatric cognitive disorders, 2006, Volume: 22, Issue:5-6

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Disorders of Excessive Somnolence; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease, Secondary; Piperazines; Thiazoles

2006
Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:5

    Topics: Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Brief Psychiatric Rating Scale; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Lipids; Male; Mental Disorders; Olanzapine; Piperazines; Retrospective Studies; Single-Blind Method; Thiazoles; Time Factors

2008
Evaluation of antideppressant properties of A-10,749.
    Current therapeutic research, clinical and experimental, 1968, Volume: 10, Issue:11

    Topics: Antidepressive Agents; Clinical Trials as Topic; Female; Humans; Male; Mental Disorders; MMPI; Placebos; Psychological Tests; Thiazoles

1968
Comparison of Abbott A-10749 imipramine.
    Current therapeutic research, clinical and experimental, 1968, Volume: 10, Issue:7

    Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Female; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Thiazoles

1968

Other Studies

32 other study(ies) available for thiazoles and Behavior Disorders

ArticleYear
Physiologically-based pharmacokinetics of ziprasidone in pregnant women.
    British journal of clinical pharmacology, 2019, Volume: 85, Issue:5

    Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Area Under Curve; Caco-2 Cells; Child; Computer Simulation; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Healthy Volunteers; Humans; Mental Disorders; Models, Biological; Piperazines; Pregnancy; Pregnancy Complications; Thiazoles

2019
Clinical lycanthropy: delusional misidentification of the "self".
    The Journal of neuropsychiatry and clinical neurosciences, 2014,Winter, Volume: 26, Issue:1

    Topics: Delusions; Dopamine Antagonists; Humans; Male; Mental Disorders; Piperazines; Self Concept; Thiazoles; Young Adult

2014
Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders.
    Human molecular genetics, 2014, Nov-01, Volume: 23, Issue:21

    Topics: Animals; Behavior, Animal; Disks Large Homolog 4 Protein; Erythropoiesis; Female; Gene Expression Regulation; Gene Order; Gene Targeting; Glutamate Decarboxylase; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mental Disorders; Mice; Mice, Transgenic; Protein Biosynthesis; Quinone Reductases; Receptors, N-Methyl-D-Aspartate; Recombinant Fusion Proteins; RNA, Long Noncoding; Scotland; Tetrazolium Salts; Thiazoles; White People

2014
Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 350, Issue:3

    Topics: Allosteric Regulation; Animals; Anti-Anxiety Agents; Disease Models, Animal; Female; Male; Mental Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Thiazoles

2014
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
    Psychiatric services (Washington, D.C.), 2015, Volume: 66, Issue:6

    Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles

2015
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2015, Volume: 54, Issue:9

    Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Multivariate Analysis; New York; Olanzapine; Parkinson Disease, Secondary; Piperazines; Prospective Studies; Quetiapine Fumarate; Regression Analysis; Risperidone; Thiazoles

2015
Low concentration of ziprasidone in human milk: a case report.
    The international journal of neuropsychopharmacology, 2009, Volume: 12, Issue:3

    Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Female; Humans; Mental Disorders; Milk, Human; Piperazines; Thiazoles; Time Factors; Young Adult

2009
Atypical antipsychotic drugs and the risk of sudden cardiac death.
    The New England journal of medicine, 2009, May-14, Volume: 360, Issue:20

    Topics: Antipsychotic Agents; Aripiprazole; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Humans; Mental Disorders; Piperazines; Quinolones; Risk; Thiazoles

2009
The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.
    Pharmacoepidemiology and drug safety, 2009, Volume: 18, Issue:9

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Cohort Studies; Diabetes Mellitus; Female; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Piperazines; Quinolones; Retrospective Studies; Thiazoles; United States

2009
Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
    Psychiatric services (Washington, D.C.), 2010, Volume: 61, Issue:2

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Drug Utilization; Evidence-Based Medicine; Female; Humans; Infant; Insurance Claim Review; Male; Medicaid; Mental Disorders; Off-Label Use; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; United States; United States Food and Drug Administration

2010
Action of aminothiazol on the development of manic access.
    Annales medico-psychologiques, 1946, Volume: 104

    Topics: Bipolar Disorder; Conversion Disorder; Hysteria; Mental Disorders; Neurosyphilis; Psychotic Disorders; Thiazoles

1946
A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Dec-24, Volume: 99, Issue:26

    Topics: Animals; Benzothiazoles; Cerebrovascular Circulation; Dopamine; Dopamine Agonists; Limbic System; Mental Disorders; Mood Disorders; Papio; Pramipexole; Prefrontal Cortex; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Tomography, Emission-Computed

2002
Ziprasidone-induced oculogyric crisis.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2003, Volume: 42, Issue:9

    Topics: Antipsychotic Agents; Child; Dystonia; Humans; Male; Mental Disorders; Ocular Motility Disorders; Piperazines; Thiazoles

2003
The S. C. T. Z. in the treatment of delirium tremens.
    Therapie, 1959, Volume: 14, Issue:3

    Topics: Humans; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders; Thiazoles

1959
A clinical evaluation of SCTZ.
    Diseases of the nervous system, 1960, Volume: 21

    Topics: Counseling; Electroconvulsive Therapy; Humans; Mental Disorders; Psychosurgery; Psychotherapy; Thiazoles

1960
[Therapeutic trial with SCTZ--a new hypnotic--in delirium tremens and allied conditions].
    Nordisk medicin, 1959, Aug-06, Volume: 62

    Topics: Alcohol Withdrawal Delirium; Anesthesia; Humans; Hypnotics and Sedatives; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders; Thiazoles

1959
[Clinical aspects of Heminevrin].
    Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry, 1963, Volume: 17

    Topics: Anticonvulsants; Chlormethiazole; Humans; Hypnotics and Sedatives; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders; Thiazoles

1963
[TREATMENT OF DELIRIUM TREMENS WITH CHLORMETHIAZOLE].
    Deutsche medizinische Wochenschrift (1946), 1964, Aug-28, Volume: 89

    Topics: Alcohol Withdrawal Delirium; Chlormethiazole; Humans; Hypnotics and Sedatives; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders; Thiazoles

1964
[THE TREATMENT OF DELIRIUM TREMENS WITH DISTRANEURIN].
    Medizinische Klinik, 1964, Sep-18, Volume: 59

    Topics: Alcohol Withdrawal Delirium; Chlormethiazole; Drug Therapy; Humans; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders; Thiamine; Thiazoles

1964
[EXPERIMENTAL REPORT ON THE APPLICATION OF DISTRANEURIN IN PSYCHIATRY].
    Wiener klinische Wochenschrift, 1964, Sep-18, Volume: 76

    Topics: Chlormethiazole; Drug Therapy; Humans; Mental Disorders; Psychiatry; Psychopharmacology; Thiazoles

1964
Periodic leg movements in prepubertal children with sleep disturbance.
    Developmental medicine and child neurology, 2004, Volume: 46, Issue:11

    Topics: Benzothiazoles; Brain; Child; Child, Preschool; Comorbidity; Diagnosis, Differential; Disorders of Excessive Somnolence; Dopamine Agonists; Fatigue Syndrome, Chronic; Female; Follow-Up Studies; Humans; Infant; Male; Mental Disorders; Nocturnal Myoclonus Syndrome; Polysomnography; Pramipexole; Prevalence; Prospective Studies; Severity of Illness Index; Thiazoles

2004
Perospirone improves food refusal in elderly patients with mental disorders.
    Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:3

    Topics: Aged; Aged, 80 and over; Eating; Female; Humans; Indoles; Isoindoles; Male; Mental Disorders; Middle Aged; Thiazoles

2005
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
    Parkinsonism & related disorders, 2005, Volume: 11, Issue:6

    Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Catechols; Databases, Factual; Dopamine Agonists; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Multiple System Atrophy; Nitriles; Parkinson Disease; Pramipexole; Sexual Dysfunctions, Psychological; Thiazoles

2005
Pathological gambling in Parkinson's disease.
    The Lancet. Neurology, 2005, Volume: 4, Issue:10

    Topics: Antiparkinson Agents; Benzothiazoles; Brain; Dopamine Agonists; Dose-Response Relationship, Drug; Gambling; Humans; Indoles; Mental Disorders; Neural Pathways; Parkinson Disease; Pramipexole; Thiazoles

2005
Real-life switching strategies with second-generation antipsychotics.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:1

    Topics: Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dibenzothiazepines; Drug Administration Schedule; Drug Resistance; Humans; Mental Disorders; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Selection Bias; Thiazoles; Treatment Outcome

2006
Perospirone in treatment of Huntington's disease: a first case report.
    Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jan-30, Volume: 31, Issue:1

    Topics: Aged; Antipsychotic Agents; Anxiety; Dopamine Antagonists; Female; Humans; Huntington Disease; Indoles; Isoindoles; Mental Disorders; Neuropsychological Tests; Serotonin Antagonists; Thiazoles

2007
Ziprasidone-associated galactorrhea in an adolescent female.
    Journal of child and adolescent psychopharmacology, 2007, Volume: 17, Issue:2

    Topics: Adolescent; Antipsychotic Agents; Female; Galactorrhea; Humans; Hyperprolactinemia; Mental Disorders; Piperazines; Thiazoles

2007
A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.
    Journal of child and adolescent psychopharmacology, 2007, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Child; Child, Preschool; Electrocardiography; Female; Hospitals, Pediatric; Humans; Injections, Intramuscular; Male; Mental Disorders; Piperazines; Psychiatric Department, Hospital; Psychiatric Status Rating Scales; Psychomotor Agitation; Regression Analysis; Retrospective Studies; Sex Factors; Sleep Stages; Thiazoles; Treatment Outcome

2007
Critical thinking about adverse drug effects: lessons from the psychology of risk and medical decision-making for clinical psychopharmacology.
    Psychotherapy and psychosomatics, 2008, Volume: 77, Issue:4

    Topics: Advertising; Benzodiazepines; Conflict of Interest; Decision Support Techniques; Drug Industry; Ethics, Medical; Evidence-Based Medicine; Humans; Marketing; Mental Disorders; Olanzapine; Piperazines; Propaganda; Psychiatry; Psychotropic Drugs; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Thiazoles; United States

2008
[Therapeutic effectiveness of thiazolidinecarboxylate of arginine in psychiatric patients with hepatic disorders of toxic origin (alcohol, drugs)].
    La Clinica terapeutica, 1979, Nov-30, Volume: 91, Issue:4

    Topics: Adult; Aged; Antidepressive Agents; Arginine; Carboxylic Acids; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Hepatitis, Alcoholic; Humans; Male; Mental Disorders; Middle Aged; Thiazoles; Tranquilizing Agents

1979
[Psychopharmacological agents in treatment of psychiatric emergencies].
    La Clinica terapeutica, 1971, Mar-31, Volume: 56, Issue:6

    Topics: Adult; Age Factors; Aged; Antidepressive Agents; Dementia; Diazepam; Haloperidol; Humans; Hypnotics and Sedatives; Mental Disorders; Middle Aged; Phenothiazines; Psychoses, Alcoholic; Suicide Prevention; Sulfonic Acids; Thiazoles; Tranquilizing Agents

1971
The clinical use of chlormethiazole.
    Acta psychiatrica Scandinavica. Supplementum, 1966, Volume: 192

    Topics: Chlormethiazole; Humans; Hypnotics and Sedatives; Mental Disorders; Sleep Initiation and Maintenance Disorders; Thiazoles

1966